Allergologie select, Volume 10 (2026) - 1st issue (280 - 284)

In-hospital sting challenge during venom immunotherapy has a high negative predictive value for subsequent sting reactions
Nicola Wagner1, Eva Oppel2, Jarmila Gloning2, Annett Walker2, Sophia Czell2, Franziska Ruëff2
1 Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität, Erlangen-Nürnberg (FAU), Erlangen, and 2 Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany

   

 

DOI 10.5414/ALX02652E

Abstract

Aims: Hymenoptera venom allergy is the most frequent elicitor of anaphylaxis in adults. Biomarkers predicting success of venom immunotherapy (VIT) are lacking. Only a re-sting may help to detect insufficiently protected individuals. The aim of the study was to investigate the prognostic value of a tolerated sting challenge with regard to future field stings. Materials and methods: A retrospective study included 585 consecutive patients of the AllergieZentrum Munich, Germany, who had tolerated a sting challenge test during VIT. Patients who were still on VIT were examined with a questionnaire evaluating the outcome of later field stings during ongoing VIT. Results: 439 of 585 patients (75%) could be evaluated. Of the 439 patients, 74/102 (75.2%) had tolerated a sting challenge with bee, 288/401 (74.1%) with yellow jacket, and 67/82 (81.7%) with both insects. In the follow-up time, 24.6% (108) had experienced at least 1 field sting. 104 of 108 patients (96.2%) had tolerated the sting without any reaction. Four patients (3.8%) reported systemic symptoms, 2 of whom experienced mild allergic immediate-type symptoms (1.9%). Conclusion: In patients on ongoing VIT a tolerated in-hospital sting provocation has a high negative predictive value (98.2%) in relation to the outcome of later field stings. The majority of these patients will subsequently not develop systemic reactions.

Author Details

Authors

Departments

  • 1 Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität, Erlangen-Nürnberg (FAU), Erlangen, and
  • 2 Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany

Address

PD Dr. med. habil. Nicola Wagner, MD, Department of Dermatology, Uniklinikum Erlangen, Ulmenweg 18, 91054 Erlangen, Germany
Email: [email protected]

Citation

Nicola Wagner, Eva Oppel, Jarmila Gloning, Annett Walker, Sophia Czell, and Franziska Ruëff. In-hospital sting challenge during venom immunotherapy has a high negative predictive value for subsequent sting reactions. Allergologie select. 2026; 10: 280-284. doi: 10.5414/ALX02652E.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart